This activity is expired and is no longer available for CME credit.


The Identification and Management of Immune-related Adverse Events in Patients with Cancer: Practice Essentials for Emergency Medicine Providers

Author(s)/Faculty: Jeffrey S. Weber, MD, PhD; Patricia Brock, MD; Rajni Kannan, BS, MS, RN, ANP-BC; Kathleen M. Madden, RN, MSN, FMP-BC, AOCMP, APHN-BC
Release Date: 3/21/2017Expiration Date: 3/16/2019
Credit Type: CME / CNENumber of Credits: 0
Content Type: VideoProvider:
The incorporation of immunotherapies, especially the immune checkpoint inhibitors, into treatment regimens for patients with cancer, have significantly improved clinical outcomes in these patient populations. The utilization of immune checkpoint inhibitors in cancer therapy are associated with unique immune-related adverse events (irAEs), most commonly manifesting in the skin, gastrointestinal tract, and endocrine system. Patients presenting with irAEs require prompt diagnosis and treatment to avoid the occurrence of potential life-threatening complications. Therefore, it is imperative that emergency medicine providers are familiar with best practices for diagnosis and management of irAEs. In this activity, a multidisciplinary expert panel provides discussion, evaluation, and guidance for the effective diagnosis, treatment, and management of irAEs in patients with cancer.